伏硫西汀（心达悦®）和左旋米那普明（瑞美隆缓释片®）：抗抑郁药物处方集里的两种最新药物。
Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary.
作者信息
Roman Marian W, Wilkinson Shannon M
机构信息
The University of Tennessee, College of Nursing , Knoxville, Tennessee , USA.
出版信息
Issues Ment Health Nurs. 2014 Dec;35(12):972-4. doi: 10.3109/01612840.2014.955155.
PMID:25426751
Abstract
In the final months of 2013, the US Food and Drug Administration approved two new antidepressant formulations. This column presents a review of the pertinent literature on both: vortioxetine (Brintellix(®)) and levomilnacipran (Fetzima(®)).
摘要
2013年最后几个月，美国食品药品监督管理局批准了两种新型抗抑郁药制剂。本专栏对有关这两种药物的相关文献进行综述：伏硫西汀（Brintellix(®)）和左旋米那普明（Fetzima(®)）。
Zotero 插件